Voice Characteristics in Patients with Acromegaly during Treatment

Thalijn L.C. Wolters; Sean H.P.P. Roerink; Linda C.A. Drenthen; Margaretha A.E.M. Wagenmakers; Guido B. van den Broek; Kim I.M. Rutten; Jasmijn M. Herruer; Adrianus R.M.M. Hermus; Romana T. Netea-Maier

doi:10.1016/j.jvoice.2020.01.006

Voice Characteristics in Patients with Acromegaly during Treatment

Thalijn L.C. Wolters^*, Sean H.P.P. Roerink, Linda C.A. Drenthen, Margaretha A.E.M. Wagenmakers, Guido B. van den Broek, Kim I.M. Rutten, Jasmijn M. Herruer, Adrianus R.M.M. Hermus, Romana T. Netea-Maier

^*Corresponding author for this work

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Abstract

Background: Active acromegaly is characterized by Growth Hormone and Insulin-like Growth Factor (IGF)-1 excess. Voice complaints are common in active acromegaly and are suggested to be caused by effects of Growth Hormone or IGF-1 on vocal folds and the surrounding soft tissues. Prospective studies on the course of voice characteristics in acromegaly patients are scarce and results are conflicting. This study investigates objective changes in voice parameters, self-reported perception of voice and laryngostroboscopic features during the first 2.5 years of acromegaly treatment. Material and Method: In this prospective study, acoustic voice analysis (and videolaryngostroboscopic examination were performed in 27 consecutive treatment-naive acromegaly patients at diagnosis (T₀), after 1 year (T₁) and after 2.5 years (T₂) of treatment. The voice handicap index (VHI-30) questionnaire was taken. Results: During acromegaly treatment, VHI scores decreased, and mucosal edema & hypertrophy diminished. No significant changes in objective voice parameters were detected. The within-subject change in serum IGF-1 levels (97.3 (40.6–208) to 22.4 (10.2–34.1) nmol/L (P < 0.001)) during follow-up correlated positively with the changes in VHI questionnaire scores (R 0.32–0.45; P = 0.002–0.03). Conclusions: At diagnosis and during acromegaly treatment, mean VHI scores were in the normal range, although they decreased during follow-up. Mucosal edema and hypertrophy largely resolved during treatment. No significant changes in objective voice parameters were observed. Voice characteristics are in the normal range in patients with acromegaly, but may change during treatment. However, voice complaints are important to discuss, since they may influence quality of life.

Original language	English
Pages (from-to)	932.e13-932.e27
Journal	Journal of Voice
Volume	35
Issue number	6
DOIs	https://doi.org/10.1016/j.jvoice.2020.01.006
Publication status	Published - 1 Nov 2021

Bibliographical note

Funding Information:
Funding: This is an investigator-initiated study sponsored through an unrestricted research grant from IPSEN Pharmaceuticals . IPSEN Pharmaceuticals had no involvement in the study design, the collection, analysis and interpretation of data, the writing of the report nor in the decision to submit the article for publication.

Publisher Copyright:
© 2020 The Voice Foundation

Access to Document

10.1016/j.jvoice.2020.01.006Licence: Unspecified

Cite this

@article{7949b1acf59c417ca7f2fc52daabeab6,

title = "Voice Characteristics in Patients with Acromegaly during Treatment",

abstract = "Background: Active acromegaly is characterized by Growth Hormone and Insulin-like Growth Factor (IGF)-1 excess. Voice complaints are common in active acromegaly and are suggested to be caused by effects of Growth Hormone or IGF-1 on vocal folds and the surrounding soft tissues. Prospective studies on the course of voice characteristics in acromegaly patients are scarce and results are conflicting. This study investigates objective changes in voice parameters, self-reported perception of voice and laryngostroboscopic features during the first 2.5 years of acromegaly treatment. Material and Method: In this prospective study, acoustic voice analysis (and videolaryngostroboscopic examination were performed in 27 consecutive treatment-naive acromegaly patients at diagnosis (T0), after 1 year (T1) and after 2.5 years (T2) of treatment. The voice handicap index (VHI-30) questionnaire was taken. Results: During acromegaly treatment, VHI scores decreased, and mucosal edema & hypertrophy diminished. No significant changes in objective voice parameters were detected. The within-subject change in serum IGF-1 levels (97.3 (40.6–208) to 22.4 (10.2–34.1) nmol/L (P < 0.001)) during follow-up correlated positively with the changes in VHI questionnaire scores (R 0.32–0.45; P = 0.002–0.03). Conclusions: At diagnosis and during acromegaly treatment, mean VHI scores were in the normal range, although they decreased during follow-up. Mucosal edema and hypertrophy largely resolved during treatment. No significant changes in objective voice parameters were observed. Voice characteristics are in the normal range in patients with acromegaly, but may change during treatment. However, voice complaints are important to discuss, since they may influence quality of life.",

author = "Wolters, {Thalijn L.C.} and Roerink, {Sean H.P.P.} and Drenthen, {Linda C.A.} and Wagenmakers, {Margaretha A.E.M.} and {van den Broek}, {Guido B.} and Rutten, {Kim I.M.} and Herruer, {Jasmijn M.} and Hermus, {Adrianus R.M.M.} and Netea-Maier, {Romana T.}",

note = "Funding Information: Funding: This is an investigator-initiated study sponsored through an unrestricted research grant from IPSEN Pharmaceuticals . IPSEN Pharmaceuticals had no involvement in the study design, the collection, analysis and interpretation of data, the writing of the report nor in the decision to submit the article for publication. Publisher Copyright: {\textcopyright} 2020 The Voice Foundation",

year = "2021",

month = nov,

day = "1",

doi = "10.1016/j.jvoice.2020.01.006",

language = "English",

volume = "35",

pages = "932.e13--932.e27",

journal = "Journal of Voice",

issn = "0892-1997",

publisher = "Mosby Inc.",

number = "6",

}

TY - JOUR

T1 - Voice Characteristics in Patients with Acromegaly during Treatment

AU - Wolters, Thalijn L.C.

AU - Roerink, Sean H.P.P.

AU - Drenthen, Linda C.A.

AU - Wagenmakers, Margaretha A.E.M.

AU - van den Broek, Guido B.

AU - Rutten, Kim I.M.

AU - Herruer, Jasmijn M.

AU - Hermus, Adrianus R.M.M.

AU - Netea-Maier, Romana T.

N1 - Funding Information: Funding: This is an investigator-initiated study sponsored through an unrestricted research grant from IPSEN Pharmaceuticals . IPSEN Pharmaceuticals had no involvement in the study design, the collection, analysis and interpretation of data, the writing of the report nor in the decision to submit the article for publication. Publisher Copyright: © 2020 The Voice Foundation

PY - 2021/11/1

Y1 - 2021/11/1

N2 - Background: Active acromegaly is characterized by Growth Hormone and Insulin-like Growth Factor (IGF)-1 excess. Voice complaints are common in active acromegaly and are suggested to be caused by effects of Growth Hormone or IGF-1 on vocal folds and the surrounding soft tissues. Prospective studies on the course of voice characteristics in acromegaly patients are scarce and results are conflicting. This study investigates objective changes in voice parameters, self-reported perception of voice and laryngostroboscopic features during the first 2.5 years of acromegaly treatment. Material and Method: In this prospective study, acoustic voice analysis (and videolaryngostroboscopic examination were performed in 27 consecutive treatment-naive acromegaly patients at diagnosis (T0), after 1 year (T1) and after 2.5 years (T2) of treatment. The voice handicap index (VHI-30) questionnaire was taken. Results: During acromegaly treatment, VHI scores decreased, and mucosal edema & hypertrophy diminished. No significant changes in objective voice parameters were detected. The within-subject change in serum IGF-1 levels (97.3 (40.6–208) to 22.4 (10.2–34.1) nmol/L (P < 0.001)) during follow-up correlated positively with the changes in VHI questionnaire scores (R 0.32–0.45; P = 0.002–0.03). Conclusions: At diagnosis and during acromegaly treatment, mean VHI scores were in the normal range, although they decreased during follow-up. Mucosal edema and hypertrophy largely resolved during treatment. No significant changes in objective voice parameters were observed. Voice characteristics are in the normal range in patients with acromegaly, but may change during treatment. However, voice complaints are important to discuss, since they may influence quality of life.

AB - Background: Active acromegaly is characterized by Growth Hormone and Insulin-like Growth Factor (IGF)-1 excess. Voice complaints are common in active acromegaly and are suggested to be caused by effects of Growth Hormone or IGF-1 on vocal folds and the surrounding soft tissues. Prospective studies on the course of voice characteristics in acromegaly patients are scarce and results are conflicting. This study investigates objective changes in voice parameters, self-reported perception of voice and laryngostroboscopic features during the first 2.5 years of acromegaly treatment. Material and Method: In this prospective study, acoustic voice analysis (and videolaryngostroboscopic examination were performed in 27 consecutive treatment-naive acromegaly patients at diagnosis (T0), after 1 year (T1) and after 2.5 years (T2) of treatment. The voice handicap index (VHI-30) questionnaire was taken. Results: During acromegaly treatment, VHI scores decreased, and mucosal edema & hypertrophy diminished. No significant changes in objective voice parameters were detected. The within-subject change in serum IGF-1 levels (97.3 (40.6–208) to 22.4 (10.2–34.1) nmol/L (P < 0.001)) during follow-up correlated positively with the changes in VHI questionnaire scores (R 0.32–0.45; P = 0.002–0.03). Conclusions: At diagnosis and during acromegaly treatment, mean VHI scores were in the normal range, although they decreased during follow-up. Mucosal edema and hypertrophy largely resolved during treatment. No significant changes in objective voice parameters were observed. Voice characteristics are in the normal range in patients with acromegaly, but may change during treatment. However, voice complaints are important to discuss, since they may influence quality of life.

UR - http://www.scopus.com/inward/record.url?scp=85078502498&partnerID=8YFLogxK

U2 - 10.1016/j.jvoice.2020.01.006

DO - 10.1016/j.jvoice.2020.01.006

M3 - Article

C2 - 32005626

AN - SCOPUS:85078502498

SN - 0892-1997

VL - 35

SP - 932.e13-932.e27

JO - Journal of Voice

JF - Journal of Voice

IS - 6

ER -

Voice Characteristics in Patients with Acromegaly during Treatment

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this